Genetic ablation of SOX18 function suppresses tumor lymphangiogenesis and metastasis of melanoma in mice

Cancer Research

Volumn 72, Issue 12, 2012, Pages 3105-3114

  Duong, Tam ^a   Proulx, Steven T ^b   Luciani, Paola ^b   Leroux, Jean Christophe ^b   Detmar, Michael ^b   Koopman, Peter ^a   Francois, Mathias ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b ETH ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

FIREFLY LUCIFERASE; LIPOSOME; TRANSCRIPTION FACTOR SOX18;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; BLOOD VESSEL DIAMETER; CANCER TRANSPLANTATION; CAPILLARY DENSITY; CONTROLLED STUDY; GENE EXPRESSION; GENE FUNCTION; GENE LOSS; IMMUNOFLUORESCENCE; LYMPH NODE; LYMPH VESSEL; LYMPHANGIOGENESIS; MELANOMA; METASTASIS; METASTASIS INHIBITION; MOUSE; NEOLYMPHANGIOGENESIS; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENTINEL LYMPH NODE; SOX18 GENE; TUMOR ABLATION; TUMOR XENOGRAFT;

ANIMALS; CELL LINE, TUMOR; LYMPHANGIOGENESIS; LYMPHATIC METASTASIS; LYMPHATIC VESSELS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUTATION; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; SOXF TRANSCRIPTION FACTORS;

EID: 84862514727     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-11-4026     Document Type: Article

References (50)

1. Tammela T, Alitalo K. Lymphangiogenesis: molecular mechanisms and future promise. Cell 2010;140:460-76.
2. Karpanen T, Alitalo K. Molecular biology and pathology of lymphangiogenesis. Annu Rev Pathol 2008;3:367-97. (Pubitemid 351488286)
3. Caunt M, Mak J, Liang WC, Stawicki S, Pan Q, Tong RK, et al. Blocking neuropilin-2 function inhibits tumor cell metastasis. Cancer Cell 2008;13:331-42. (Pubitemid 351446192)
4. Mumprecht V, Detmar M. Lymphangiogenesis and cancer metastasis. J Cell Mol Med 2009;13:1405-16.
5. Achen MG, McColl BK, Stacker SA. Focus on lymphangiogenesis in tumor metastasis. Cancer Cell 2005;7:121-7. (Pubitemid 40248338)
6. Alitalo K, Tammela T, Petrova TV. Lymphangiogenesis in development and human disease. Nature 2005;438:946-53. (Pubitemid 43093960)
7. Hirakawa S, Kodama S, Kunstfeld R, Kajiya K, Brown LF, Detmar M. VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J Exp Med 2005;201:1089-99. (Pubitemid 40524677)
8. Hirakawa S, Brown LF, Kodama S, Paavonen K, Alitalo K, Detmar M. VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites. Blood 2007;109:1010-7. (Pubitemid 46220646)
9. Tobler NE, Detmar M. Tumor and lymph node lymphangiogenesis- impact on cancer metastasis. J Leukoc Biol 2006;80:691-6. (Pubitemid 44835883)
10. Joyce JA, Pollard JW. Microenvironmental regulation of metastasis. Nat Rev Cancer 2009;9:239-52.
11. Ran S, Volk L, Hall K, Flister MJ. Lymphangiogenesis and lymphatic metastasis in breast cancer. Pathophysiology 2010;17:229-51.
12. Stacker SA, Achen MG, Jussila L, Baldwin ME, Alitalo K. Lymphangiogenesis and cancer metastasis. Nat Rev Cancer 2002;2:573-83. (Pubitemid 37328924)
13. Koch M, Dettori D, Van Nuffelen A, Souffreau J, Marconcini L, Wallays G, et al. VEGF-D deficiency in mice does not affect embryonic or postnatal lymphangiogenesis but reduces lymphatic metastasis. J Pathol 2009;219:356-64.
14. Tammela T, He Y, Lyytikka J, Jeltsch M, Markkanen J, Pajusola K, et al. Distinct architecture of lymphatic vessels induced by chimeric vascular endothelial growth factor-C/vascular endothelial growth factor hepa-rin- binding domain fusion proteins. Circ Res 2007;100:1468-75. (Pubitemid 46834759)
15. He Y, Rajantie I, Pajusola K, Jeltsch M, Holopainen T, Yla-Herttuala S, et al. Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels. Cancer Res 2005;65:4739-46. (Pubitemid 40740810)
16. Roberts N, Kloos B, Cassella M, Podgrabinska S, Persaud K, Wu Y, et al. Inhibition of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR-2. Cancer Res 2006;66:2650-7.
17. Burton JB, Priceman SJ, Sung JL, Brakenhielm E, An DS, Pytowski B, et al. Suppression of prostate cancer nodal and systemic metastasis by blockade of the lymphangiogenic axis. Cancer Res 2008;68:7828-37.
18. Xu Y, Yuan L,MakJ, Pardanaud L, Caunt M, Kasman I, et al. Neuropilin- 2 mediates VEGF-C-induced lymphatic sprouting together with VEGFR3. J Cell Biol 2010;188:115-30.
19. Wigle JT, Oliver G. Prox1 function is required for the development of the murine lymphatic system. Cell 1999;98:769-78. (Pubitemid 29446894)
20. Francois M, Caprini A, Hosking B, Orsenigo F, Wilhelm D, Browne C, et al. Sox18 induces development of the lymphatic vasculature in mice. Nature 2008;456:643-7.
21. Srinivasan RS, Geng X, Yang Y, Wang Y, Mukatira S, Studer M, et al. The nuclear hormone receptor Coup-TFII is required for the initiation and early maintenance of Prox1 expression in lymphatic endothelial cells. Genes Dev 2010;24:696-707.
22. Hosking BM, Muscat GE, Koopman PA, Dowhan DH, Dunn TL. Transactivation and DNA-binding properties of the transcription factor, Sox-18. Nucleic Acids Res 1995;23:2626-8.
23. Hosking BM, Wyeth JR, Pennisi DJ, Wang SC, Koopman P, Muscat GE. Cloning and functional analysis of the Sry-related HMG box gene, Sox18. Gene 2001;262:239-47. (Pubitemid 32155355)
24. Darby IA, Bisucci T, Raghoenath S, Olsson J, Muscat GE, Koopman P. Sox18 is transiently expressed during angiogenesis in granulation tissue of skin wounds with an identical expression pattern to Flk-1 mRNA. Lab Invest 2001;81:937-43. (Pubitemid 32645968)
25. Young N, Hahn CN, Poh A, Dong C, Wilhelm D, Olsson J, et al. Effect of disrupted SOX18 transcription factor function on tumor growth, vascularization, and endothelial development. J Natl Cancer Inst 2006;98:1060-7. (Pubitemid 44288154)
26. Downes M, Francois M, Ferguson C, Parton RG, Koopman P. Vascular defects in a mouse model of hypotrichosis-lymphedema-telangiectasia syndrome indicate a role for SOX18 in blood vessel maturation. Hum Mol Genet 2009;18:2839-50.
27. Eom BW, Jo MJ, Kook MC, Ryu KW, Choi IJ, Nam BH, et al. The lymphangiogenic factor SOX 18: a key indicator to stage gastric tumor progression. Int J Cancer 2012;131:41-8.
28. Azhikina T, Kozlova A, Skvortsov T, Sverdlov E. Heterogeneity and degree of TIMP4, GATA4, SOX18, and EGFL7 gene promoter methylation in non-small cell lung cancer and surrounding tissues. Cancer Genet 2011;204:492-500.
29. Pennisi D, Bowles J, Nagy A, Muscat G, Koopman P. Mice null for sox18 are viable and display a mild coat defect. Mol Cell Biol 2000;20:9331-6. (Pubitemid 32246117)
30. Hosking B, Francois M, Wilhelm D, Orsenigo F, Caprini A, Svingen T, et al. Sox7 and Sox17 are strain-specific modifiers of the lymphangiogenic defects caused by Sox18 dysfunction in mice. Development 2009;136:2385-91.
31. Hope MJ, Bally MB, Webb G, Cullis PR. Characterization of size distribution, trapped volume and ability to maintain a membrane potential. Biochim Biophys Acta 1985;812:55-65.
32. Proulx ST, Luciani P, Derzsi S, Rinderknecht M, Mumprecht V, Leroux JC, et al. Quantitative imaging of lymphatic function with liposomal indocyanine green. Cancer Res 2010;70:7053-62.
33. Shayan R, Karnezis T, Tsantikos E, Williams SP, Runting AS, Ashton MW, et al. A system for quantifying the patterning of the lymphatic vasculature. Growth Factors 2007;25:417-25. (Pubitemid 351455007)
34. Harrell MI, Iritani BM, Ruddell A. Tumor-induced sentinel lymph node lymphangiogenesis and increased lymph flow precede melanoma metastasis. Am J Pathol 2007;170:774-86. (Pubitemid 47339411)
35. Ishii H, Chikamatsu K, Sakakura K, Miyata M, Furuya N, Masuyama K. Primary tumor induces sentinel lymph node lymphangiogenesis in oral squamous cell carcinoma. Oral Oncol 2010;46:373-8.
36. Giampieri S, Pinner S, Sahai E. Intravital imaging illuminates transforming growth factor beta signaling switches during metastasis. Cancer Res 2010;70:3435-9.
37. Al-Rawi MA, Watkins G, Mansel RE, Jiang WG. Interleukin 7 upregulates vascular endothelial growth factor D in breast cancer cells and induces lymphangiogenesis in vivo. Br J Surg 2005;92:305-10. (Pubitemid 40445592)
38. Hoshida T, Isaka N, Hagendoorn J, di Tomaso E, Chen YL, Pytowski B, et al. Imaging steps of lymphatic metastasis reveals that vascular endothelial growth factor-C increases metastasis by increasing delivery of cancer cells to lymph nodes: therapeutic implications. Cancer Res 2006;66:8065-75. (Pubitemid 44299172)
39. Baluk P, Yao LC, Feng J, Romano T, Jung SS, Schreiter JL, et al. TNFalpha drives remodeling of blood vessels and lymphatics in sustained airway inflammation in mice. J Clin Invest 2009;119:2954-64.
40. Baluk P, Fuxe J, Hashizume H, Romano T, Lashnits E, Butz S, et al. Functionally specialized junctions between endothelial cells of lymphatic vessels. J Exp Med 2007;204:2349-62. (Pubitemid 47529321)
41. Fontijn RD, Volger OL, Fledderus JO, Reijerkerk A, de Vries HE, Horrevoets AJ. SOX-18 controls endothelial-specific claudin-5 gene expression and barrier function. Am J Physiol Heart Circ Physiol 2008;294:H891-900. (Pubitemid 351253301)
42. Hosking BM, Wang SC, Downes M, Koopman P, Muscat GE. The VCAM-1 gene that encodes the vascular cell adhesion molecule is a target of the Sry-related high mobility group box gene, Sox18. J Biol Chem 2004;279:5314-22. (Pubitemid 38220552)
43. Groves RW, Ross EL, Barker JN, MacDonald DM. Vascular cell adhesion molecule-1: expression in normal and diseased skin and regulation in vivo by interferon gamma. J Am Acad Dermatol 1993;29:67-72. (Pubitemid 23197199)
44. Rice GE, Bevilacqua MP. An inducible endothelial cell surface glycoprotein mediates melanoma adhesion. Science 1989;246:1303-6. (Pubitemid 20066715)
45. Langley RR, Carlisle R, Ma L, Specian RD, Gerritsen ME, Granger DN. Endothelial expression of vascular cell adhesion molecule-1 correlates with metastatic pattern in spontaneous melanoma. Microcirculation 2001;8:335-45. (Pubitemid 33598137)
46. de la Monte SM, Moore GW, Hutchins GM. Patterned distribution of metastases from malignant melanoma in humans. Cancer Res 1983;43:3427-33. (Pubitemid 13061609)
47. He Y, Rajantie I, Ilmonen M, Makinen T, Karkkainen MJ, Haiko P, et al. Preexisting lymphatic endothelium but not endothelial progenitor cells are essential for tumor lymphangiogenesis and lymphatic metastasis. Cancer Res 2004;64:3737-40. (Pubitemid 38697279)
48. Lin FJ, Chen X, Qin J, Hong YK, Tsai MJ, Tsai SY. Direct transcriptional regulation of neuropilin-2 by COUP-TFII modulates multiple steps in murine lymphatic vessel development. J Clin Invest 2010;120:1694-707.
49. Zumsteg A, Baeriswyl V, Imaizumi N, Schwendener R, Ruegg C, Christofori G. Myeloid cells contribute to tumor lymphangiogenesis. PLoS One 2009;4:e7067.
50. Downes M, Koopman P. SOX18 and the transcriptional regulation of blood vessel development. Trends Cardiovasc Med 2001;11:318-24. (Pubitemid 33116304)